国际皮肤性病学杂志    2002 28 (6): 365-367   ISSN: 2096-5540  CN: 32-1880/R  

Fractalkine及其受体与皮肤病
鲍彰, 郑敏
浙江大学医学院附属第二医院皮肤科, 杭州310009
收稿日期 2002-02-27  修回日期 null  网络版发布日期 null
参考文献  [1] Pan Y, Lloyd C, Zhou H, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature, 1997, 387(6633):611-617.
[2] Bazan JF, Bacon KB, Hardiman G, et al. A new class of membranebound chemokine with a CX3C motif. Nature, 1997, 385 (6617):640-644.
[3] Fong AM, Erickson HP, Zachariah JP, et al. Ultrastructure and function of the fractalkine mucin domain in CX (3) C chemokine domain presentation. J Biol Chem, 2000, 275(6):3781-3786.
[4] Haskell CA, Cleary MD, Charo IF. Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion. J Biol Chem, 2000, 275 (44):34183-34189.
[5] Haskell CA, Cleary MD, Charo IF. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem, 1999, 274(15):10053-10058.
[6] Fong AM, Robinson LA, Steeber DA, et al. Fraetalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med, 1998, 188 (8):1413-1419.
[7] Raport CJ, Schweickart VL, Eddy RL Jr, et al. The orphan G-protein-coupled receptor-encoding gene V28 is closely related to genes for chemokine receptors and is expressed in lymphoid and neural tissues.Gene, 1995, 163(2):295-299.
[8] Combadiere C, Salzwedel K, Smith ED, et al. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J Biol Chem, 1998,273 (37):23799-23804.
[9] Chen S, Bacon KB, Li L, et al. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-Ⅱ. J Exp Med, 1998,188(1):193-198.
[10] Cockwell P, Chakravorty SJ, Girdlestone J, et al. Fractalkine expression in human renal inflammation. J Pathol, 2002, 196(1):85-90.
[11] Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest, 2001,107(9):1173-1181.
[12] Raychaudhuri SP, Jiang WY, Farber EM. Cellular localization of fractalkine at sites of inflammation:antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol, 2001, 144 (6):1105-1113.
[13] Muehlhoefer A, Saubermann LJ, Gu X, et al. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol, 2000, 164(6):3368-3376.
[14] Papadopoulos EJ, Sassetti C, Saeki H,et al. Fractalkine, a CX3Cchemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol, 1999, 29(8):2551-2559.
[15] Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell, 1997, 91 (4):521-530.
[16] Werb Z, Yan Y. A cellular striptease act. Science, 1998, 282(5392):1279-1280.
[17] Garton KJ, Gough PJ, Blobel CP, et al. Tumor necrosis factor-alphaconverting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem, 2001,276(41):37993-38001.
[18] Cambien B, Pomeranz M, Schmid-Antomarchi H, et al. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood, 2001,97(7):2031-2037.
[19] Kansra V, Groves C, Gutierrez-Ramos JC, et al. Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX (3)CR1-mediated activation of the mitogen-activated protein kinase cascade. J Biol Chem, 2001, 276(34):31831-31838.
[20] Nestle FO, Nickoloff BJ. Dermal dendritic cells are important members of the skin immune system. Adv Exp Med Biol, 1995, 378:111-116.
[21] Chan J, Smoller BR, Raychauduri SP, et al. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res, 1997, 289(11):611-616.
[22] Faure S, Meyer L, Costagliola D, et al. Rapid progression to AIDS in HIV + individuals with a structural variant of the chemokine receptor CX3CR1. Science, 2000, 287(5461):2274-2277.
[23] McDermott DH, Colla JS, Kleeberger CA, et al. Genetic polymorphism in CX3CR1 and risk of HIV disease. Science, 2000, 290(5499):2031.
[24] Foussat A, Bouchet-Delbos L, Berrebi D,et a. Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. Blood, 2001,98(6):1678-1686.

通讯作者: